These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7673380)

  • 1. Correlation of CGS 19755 neuroprotection against in vitro excitotoxicity and focal cerebral ischemia.
    Pérez-Pinzón MA; Maier CM; Yoon EJ; Sun GH; Giffard RG; Steinberg GK
    J Cereb Blood Flow Metab; 1995 Sep; 15(5):865-76. PubMed ID: 7673380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotection by the N-methyl-D-aspartate receptor antagonist CGP 40116: in vivo and in vitro studies.
    Maier CM; Sun GH; Kunis DM; Giffard RG; Steinberg GK
    J Neurochem; 1995 Aug; 65(2):652-9. PubMed ID: 7616221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The competitive NMDA receptor antagonist CGP 40116 is a potent neuroprotectant in a rat model of focal cerebral ischemia.
    Sauer D; Allegrini PR; Fagg GE
    J Neural Transm Suppl; 1994; 43():81-9. PubMed ID: 7884410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of brain protection by N-methyl-D-aspartate receptor antagonists after transient focal ischemia in cats.
    Miyabe M; Kirsch JR; Nishikawa T; Koehler RC; Traystman RJ
    Crit Care Med; 1997 Jun; 25(6):1037-43. PubMed ID: 9201058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection after transient focal cerebral ischemia by the N-methyl-D-aspartate antagonist dextrorphan is dependent upon plasma and brain levels.
    Steinberg GK; Kunis D; Saleh J; DeLaPaz R
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):1015-24. PubMed ID: 1939379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of a competitive NMDA receptor antagonist (CGS-19755) on cerebral blood flow and pH in focal ischemia.
    Takizawa S; Hogan M; Hakim AM
    J Cereb Blood Flow Metab; 1991 Sep; 11(5):786-93. PubMed ID: 1831460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo distribution of CGS-19755 within brain in a model of focal cerebral ischemia.
    Hogan MJ; Gjedde A; Hakim AM
    J Neurochem; 1992 Jan; 58(1):186-91. PubMed ID: 1727429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid on focal cerebral ischemia in cat.
    Okada M; Ueda H; Kometani M; Nakao K
    Arzneimittelforschung; 1997 Jun; 47(6):703-5. PubMed ID: 9239446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPD 502: a water-soluble and in vivo long-lasting AMPA antagonist with neuroprotective activity.
    Nielsen EO; Varming T; Mathiesen C; Jensen LH; Moller A; Gouliaev AH; Wätjen F; Drejer J
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1492-501. PubMed ID: 10336544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNX-111, a novel, presynaptic N-type calcium channel antagonist, is neuroprotective against focal cerebral ischemia in rabbits.
    Perez-Pinzon MA; Yenari MA; Sun GH; Kunis DM; Steinberg GK
    J Neurol Sci; 1997 Dec; 153(1):25-31. PubMed ID: 9455974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The action of CGS-19755 on the redox enhancement of NMDA toxicity in rat cortical neurons in vitro.
    Aizenman E; Hartnett KA
    Brain Res; 1992 Jul; 585(1-2):28-34. PubMed ID: 1511311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of the allosteric agonist of metabotropic glutamate receptor 7 AMN082 on oxygen-glucose deprivation- and kainate-induced neuronal cell death.
    Domin H; Jantas D; Śmiałowska M
    Neurochem Int; 2015 Sep; 88():110-23. PubMed ID: 25576184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of neuroprotective effects of erythropoietin (EPO) and carbamylerythropoietin (CEPO) against ischemia-like oxygen-glucose deprivation (OGD) and NMDA excitotoxicity in mouse hippocampal slice cultures.
    Montero M; Poulsen FR; Noraberg J; Kirkeby A; van Beek J; Leist M; Zimmer J
    Exp Neurol; 2007 Mar; 204(1):106-17. PubMed ID: 17157835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dextromethorphan alters cerebral blood flow and protects against cerebral injury following focal ischemia.
    Steinberg GK; Lo EH; Kunis DM; Grant GA; Poljak A; DeLaPaz R
    Neurosci Lett; 1991 Dec; 133(2):225-8. PubMed ID: 1816501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid in the gerbil model of transient global cerebral ischemia.
    Okada M; Ueda H; Kometani M; Nakao K; Kohjimoto Y; Takahashi I; Tanaka I
    Arzneimittelforschung; 1997 Jun; 47(6):700-2. PubMed ID: 9239445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel multi-target ligand (JM-20) protects mitochondrial integrity, inhibits brain excitatory amino acid release and reduces cerebral ischemia injury in vitro and in vivo.
    Nuñez-Figueredo Y; Ramírez-Sánchez J; Hansel G; Simões Pires EN; Merino N; Valdes O; Delgado-Hernández R; Parra AL; Ochoa-Rodríguez E; Verdecia-Reyes Y; Salbego C; Costa SL; Souza DO; Pardo-Andreu GL
    Neuropharmacology; 2014 Oct; 85():517-27. PubMed ID: 24953828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between N-methyl-D-aspartate and CGS 19755 administered intramuscularly and intracerebroventricularly in pigeons.
    France CP; Lu Y; Woods JH
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1271-7. PubMed ID: 2262905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regionally selective effects of NMDA receptor antagonists against ischemic brain damage in the gerbil.
    Warner MA; Neill KH; Nadler JV; Crain BJ
    J Cereb Blood Flow Metab; 1991 Jul; 11(4):600-10. PubMed ID: 1828809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebroside-A provides potent neuroprotection after cerebral ischaemia through reducing glutamate release and Ca²⁺ influx of NMDA receptors.
    Li L; Yang R; Sun K; Bai Y; Zhang Z; Zhou L; Qi Z; Qi J; Chen L
    Int J Neuropsychopharmacol; 2012 May; 15(4):497-507. PubMed ID: 21557879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection by N-methyl-D-aspartate antagonists in focal cerebral ischemia is dependent on continued maintenance dosing.
    Steinberg GK; Yoon EJ; Kunis DM; Sun GH; Maier CM; Grant GA
    Neuroscience; 1995 Jan; 64(1):99-107. PubMed ID: 7708219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.